Clinical trials: Clinical Sepsis
Pneumonia, Bloodstream Infection
Clinical Outcomes in Patients With Infection by Resistant Microorganism
The goal of this individual patient data meta-analysis is to estimate the attributed and the associated health burden related to bloodstream infections, pneumonia, skin and soft tissue infections, surgical site infections and…
- Conditions
- Pneumonia, Bloodstream Infection, Urinary Tract Infections, Skin Infection
- Trial name
- NCT05880069
- Testing
- Pathogen resistant phenotype
- Where
- Spain
- Volunteers
- 5,000 people
- Sponsor
- Hospital Universitario Virgen Macarena
Sepsis, Infection
CV-SQuISH-ED: Clinical Validation Study
This is a study to evaluate the diagnostic performance of the investigational Cytovale System \& IntelliSep Test as a diagnostic marker of sepsis in a population of patients presenting to the emergency department with signs or…
- Trial name
- NCT04933760
- Testing
- Cytovale IntellipSep test
- Where
- 4 sites in United States
- Volunteers
- 599 people
- Sponsor
- Cytovale, Inc.
Bacterial Sepsis
Therapeutic Monitoring of Beta-lactams in Critically Ill Patients With Sepsis
Background: Sepsis is a leading cause of morbidity and mortality among critically ill patients and is associated with intensive use of β-lactam antibiotics.
- Trial name
- NCT07270523
- Testing
- Individualized dosing of beta-lactam antibiotics based on therapeutic monitoring
- Where
- Spain
- Volunteers
- 198 people
- Sponsor
- Complexo Hospitalario Universitario de A Coruña
Sepsis, Infections
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
Fecal microbial transplantation is to transplant functional microbiota from the feces of healthy people into the gastrointestinal tract of patients, reconstruct new intestinal microbiota, and realize the treatment of intestinal…
- Trial name
- NCT05578196
- Testing
- fecal bacteria solution, physiological saline solution
- Where
- China
- Volunteers
- 110 people
- Sponsor
- Shanghai 10th People's Hospital
Sepsis, Deterioration, Clinical
Hospital-Onset Sepsis Systematic Detection and Structured Interventions
Sepsis is a life-threatening reaction to an infection. It can begin while a person is already in the hospital for some other reason. Sepsis that starts in the hospital is often recognized late, and treatment can be delayed.
- Conditions
- Sepsis, Deterioration, Clinical, Critical Illness, Early Warning Score
- Trial name
- CATCH SEPSIS (NCT07804251)
- Testing
- Algorithm-triggered sepsis alert with structured critical care team activation
- Where
- United States
- Volunteers
- 3,700 people
- Sponsor
- Patricks Lyons
Critical Illness
Infusion Set Replacement Intervals for Critically Ill Patients
This study aimed to evaluate the efficacy of 24-hour versus 96-hour infusion set replacement to prevent central line-associated bloodstream infection (CLABSI) in critically ill adults with central venous access devices.
- Trial name
- NCT05359601
- Testing
- Infusion set replacement intervals
- Where
- China
- Volunteers
- 1,240 people
- Sponsor
- Zhongnan Hospital
Methicillin-resistant Staphylococcus Aureus, Sepsis
Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project
Determine if a cystatin C-inclusive vancomycin dosing algorithm improved target trough achievement compared to creatinine clearance-guided vancomycin therapy in critically ill patients.
- Conditions
- Methicillin-resistant Staphylococcus Aureus, Sepsis, Critical Illness
- Trial name
- NCT02945241
- Testing
- Vancomycin, Cystatin C dosing algorithm, Creatine clearance dosing algorithm
- Volunteers
- 399 people
- Sponsor
- Mayo Clinic
Catheter-related Bloodstream Infection
SQ53 Disinfectant Wipes for Prevention of CRBSI
SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and fungal pathogens.
- Trial name
- NCT04822467
- Testing
- SQ53 Wipe, Ethanol Wipe
- Where
- United States
- Volunteers
- 59 people
- Sponsor
- The Cleveland Clinic
Sepsis, Infection
Heparin Binding Protein in Early Sepsis Diagnosis
The primary objective of this study is to use heparin-binding protein (HBP) concentration to indicate the presence, or outcome, of sepsis over 72 hours after ED admission.
- Trial name
- PROMPT (NCT03295825)
- Testing
- Biomarker
- Where
- 6 sites in Greece
- Volunteers
- 400 people
- Sponsor
- Hellenic Institute for the Study of Sepsis
Sepsis, Electronic Health Records
Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients
The goal of this clinical trial is to study systemic inflammatory response syndrome (SIRS) electronic health record (EHR) alerts for sepsis in the inpatient setting.
- Conditions
- Sepsis, Electronic Health Records, Clinical Decision Support Systems
- Trial name
- SEPTIC-IP (NCT06117618)
- Testing
- Nurse SIRS alert, Prescribing clinician SIRS alert
- Where
- United States
- Volunteers
- 12,284 people
- Sponsor
- Columbia University
Bloodstream Infection, Septic Shock
Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes
Continual surveillance of both community-acquired and nosocomial bloodstream infections for specific target organisms. Analysis of comorbidities, complications, bacterial resistance patterns, bacterial genomics (e. g.
- Trial name
- BLOOMY-COM (NCT03578835)
- Where
- 6 sites in Germany
- Volunteers
- 6,000 people
- Sponsor
- University Hospital Tuebingen
Sepsis
Hemospec Device for the Diagnosis of Sepsis
A diagnostic devise, namely HemoSpec, had been developed that integrates clinical information, along with information on circulating protein biomarkers and the morphology of white blood cells to achieve early diagnosis of sepsis.
- Trial name
- INTELLIGENCE-1 (NCT03306186)
- Testing
- HemoSpec
- Where
- 5 sites in Greece
- Volunteers
- 183 people
- Sponsor
- University of Athens
LRTI, UTI
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
This is an observational prospective study of an in-vitro diagnostic (IVD) assay planned to enroll 632 subjects. The study will be conducted in two stages: Stage A is aimed at identifying individual biomarkers and constructing a…
- Conditions
- LRTI, UTI, Gastroenteritis, Systemic Infections/Bacteremia/Meningitis
- Trial name
- CURIOSITY (NCT01917461)
- Where
- 2 sites in Israel
- Volunteers
- 1,001 people, healthy volunteers welcome
- Sponsor
- MeMed Diagnostics Ltd.
Sepsis
The Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Test (Multiplex PCR FilmArray) on Antimicrobial Decision Making Compared to Conventional Decision Making Among Critically Ill Patients
We will show in this study the impact of use the rapid diagnostic method (multiplex PCR filmArray) on clinical and pharmacoeconomic aspects among Critically Ill Patients.
- Trial name
- NCT05759494
- Testing
- rapid diagnostic test (multiplex PCR filmArray)
- Volunteers
- 100 people
- Sponsor
- Cairo University
Post Abdominal Surgery, Sepsis Abdominal
Clinical Effects of Ringers Lactate Versus Sterofundin/ Plasmalyte Solution in Patients With Sepsis
The goal of this clinical trial is to compare the clinical effects of using Ringer's Lactate and Sterofundin/ Plasmalyte as maintenance fluids in adult patients who have undergone abdominal surgery and are septic.
- Trial name
- NCT07239713
- Testing
- Ringer's Lactate Crystalloid Solutions, Sterofundin (Bolus of crystalloids)
- Where
- Pakistan
- Volunteers
- 82 people
- Sponsor
- CMH Lahore Medical College and Institute of Dentistry
Sepsis, Septic Shock
PRIME Sepsis Trial: Early Sepsis Detection in the Emergency Department Using Presepsin and Immature Granulocytes
Early identification and timely intervention for sepsis in the emergency department (ED) are critical for improving patient outcomes.
- Trial name
- NCT07822412
- Where
- Taiwan
- Volunteers
- 699 people
- Sponsor
- Chang Gung Memorial Hospital
Sepsis Affecting Skin, Central Venous Catheter Related Bacteremia
Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia
A multicentre, open-label clinical trial of two groups comparing cutaneous asepsis with chlorhexidine gluconate at 2% + isopropyl alcohol 70% in relation to the placement of central venous catheters (Study group) with standard…
- Trial name
- NCT03489512
- Testing
- A (Chloraprep), B (Clorhexidine 2%)
- Sponsor
- Instituto de Investigacion Sanitaria La Fe
Bacteremia, Tooth Extraction Status Nos
Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols
The first time the American Heart Association (AHA) suggested that disinfection of the gingival sulcus be performed as a complement to antibiotic prophylaxis in patients considered to be at risk of Infective endocarditis (IE) was…
- Trial name
- NCT02150031
- Testing
- 0.2% Chlorhexidine, 1% Chlorhexidine, Blood extraction
- Where
- 2 sites in Portugal, Spain
- Volunteers
- 208 people, healthy volunteers welcome
- Sponsor
- University of Santiago de Compostela
Bacteremia, Intensive Care
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
The World Health Organization, U.S. Centers for Disease Control and Prevention, Association of Medical Microbiology and Infectious Diseases (AMMI) Canada, and Health Canada have all declared antimicrobial resistance a global…
- Conditions
- Bacteremia, Intensive Care, Critically Ill, Sepsis
- Trial name
- BALANCE (NCT03005145)
- Testing
- 7 days of adequate antibiotic treatment, 14 days of adequate antibiotic treatment.
- Where
- 68 sites in United States, Australia and 5 more
- Volunteers
- 3,622 people
- Sponsor
- Sunnybrook Health Sciences Centre
Hospital Admission Duration, Postoperative Hematoma Formation
Drain or no Drain After Thyroid Surgery: a Randomized Clinical Trial at Mulago Hospital
Thyroidectomy is one of the most commonly performed operations in general surgery. Available data seem to suggest an association between no-drain usage and a shorter duration of hospital stay.
- Conditions
- Hospital Admission Duration, Postoperative Hematoma Formation, Wound Sepsis
- Trial name
- NCT01729741
- Testing
- drain was inserted after thyroid surgery
- Where
- 2 sites in Uganda
- Volunteers
- 68 people
- Sponsor
- Makerere University